Delivery Order SPE2DB22D2006-SPE2DB25FW3AT
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, valued at $2,292.52, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gentamicin is a critical antibiotic used in military...
- The Defense Logistics Agency awarded a $2,287.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Gentamicin 800 mg/20 mL vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,286.51, is for the delivery of 4,568,577,972 vials of 800 mg/20 mL Gentamicin, a pharmaceutical product used for treating various bacterial infections. The contract has an ultimate completion date of June 18, 2025 and is not set aside for any specific business type....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gentamicin 800 mg/20 ml vials with a firm fixed price ceiling value of $2,425.09. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- This is a $2,741.83 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 800 mg/20 ml vials of the antibiotic Gentamicin, with a performance period through May 12, 2023. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a...
- The Defense Logistics Agency awarded a $445.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 milliliter vials of the antibiotic gentamicin. The place of performance is Conshohocken, Pennsylvania. The delivery order runs from July 14, 2023 through July 17, 2023 to supply gentamicin, a broad-spectrum aminoglycoside antibiotic, under the DLA's pharmaceutical products program. Amerisourcebergen will perform as the prime contractor to fulfill this requirement for...
- This is a $1,392.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566811385 - GENTAMICIN 800 MG/20 ML VIAL 20ML, with a period of performance ending on December 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for GENTAMICIN 800 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of February 16, 2024 and a potential value of $3,436.19. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gentamicin 800 mg/20 ml vials, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,601.05 and a completion date of July 10, 2025. It is not a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor and there are no...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,376,424 units of Gentamicin 800 mg/20 ml vial, with a total ceiling value of $11,590.12. The contract is a Delivery Order, with a Firm Fixed Price pricing type, placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3ATDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,381.58 to AmerisourceBergen Drug Corp for the supply of Gentamicin 80 mg/2 ml vials on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gentamicin is a critical antibiotic used extensively throughout military and federal healthcare systems for treating bacterial infections across multiple therapeutic applications. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military healthcare programs and federal medical procurement needs. The company's role as a critical pharmaceutical distributor positions it to fulfill federal requirements for essential medications including antibiotics, specialty drugs, vaccines, and related medical supplies across the DLA's global medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/1/25 |